07-31-2006, 08:39 AM
A A 45-year-old woman with a history of myasthenia gravis presents with severe, generalized weakness. There has been no change in her pyridostigmine dose. A Tensilon test is performed which results in increased muscle weakness. Of the following, which is the MOST IMPORTANT treatment consideration?
*a. Closely monitor respiratory status
b. Give atropine and titrate to symptoms
c. Increase patient pyridostigmine
d. Initiate pralidoxime treatment
e. Prepare for possible plasmapharesis
*a. Closely monitor respiratory status
b. Give atropine and titrate to symptoms
c. Increase patient pyridostigmine
d. Initiate pralidoxime treatment
e. Prepare for possible plasmapharesis